APA (7th ed.) Citation

Miles, D. W., Gligorov, J., André, F., Cameron, D., Schneeweiss, A., Barrios, C., . . . Tabane, K. (2021). Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer. Annals of oncology, 32(8), . https://doi.org/10.1016/j.annonc.2021.05.801

Chicago Style (17th ed.) Citation

Miles, David W., et al. "Primary Results from IMpassion131, a Double-blind, Placebo-controlled, Randomised Phase III Trial of First-line Paclitaxel with or Without Atezolizumab for Unresectable Locally Advanced/metastatic Triple-negative Breast Cancer." Annals of Oncology 32, no. 8 (2021). https://doi.org/10.1016/j.annonc.2021.05.801.

MLA (9th ed.) Citation

Miles, David W., et al. "Primary Results from IMpassion131, a Double-blind, Placebo-controlled, Randomised Phase III Trial of First-line Paclitaxel with or Without Atezolizumab for Unresectable Locally Advanced/metastatic Triple-negative Breast Cancer." Annals of Oncology, vol. 32, no. 8, 2021, https://doi.org/10.1016/j.annonc.2021.05.801.